Operationalising factors that explain the emergence of infectious diseases : A case study of the human campylobacteriosis epidemic

Peer reviewedPublisher PD

Phylogeographic analysis reveals multiple international transmission events have driven the global emergence of Escherichia coli O157:H7

This work was supported by: Scotland by Food Standards Scotland [Grant Number FS102029] and University of Aberdeen; New Zealand, Institute of Environmental Science and Research; Canada, the Public Health Agency of Canada; United States, United States Department of AgriculturePeer reviewedPostprin

Assessing outcomes of alcohol-related brain damage (ARBD): What should we be measuring?

The recent move towards outcomes-focused assessment in health and social care has made it important to identify which outcomes are relevant to alcohol-related brain damage (ARBD). Clinical outcomes guidance for ARBD is currently absent from policy documentation. Thus, the aim of this review is to evaluate the current evidence base to determine recommendations for the measurement of ARBD outcomes. A total of 71 separate references were identified through a systematic online database and hand search. The screening and exclusion strategy left 7 articles to be included in this review. The findings indicate that research into ARBD has focussed on a number of outcome domains, including type of accommodation and provision of support; drinking status; employment status; number of deaths; mental health and psychiatric symptoms; activities of daily living; social functioning; and cognitive functioning. The identified outcomes suggest that practitioners should focus on a comprehensive range of clinical outcomes for ARBD service users. Nevertheless, the paucity of the existing evidence base makes it difficult to make clinical recommendations for the measurement of ARBD outcomes. Further research is necessary to shed light on long term outcomes for people with ARBD and to increase the strength of the evidence in this area

Measurement of the beam-helicity asymmetry in photoproduction of π0η pairs on carbon, aluminum, and lead

The beam-helicity asymmetry was measured, for the first time, in photoproduction of π0η pairs on carbon, aluminum, and lead, with the A2 experimental setup at MAMI. The results are compared to an earlier measurement on a free proton and to the corresponding theoretical calculations. The Mainz model is used to predict the beam-helicity asymmetry for the nuclear targets. The present results indicate that the photoproduction mechanism for π0η pairs on nuclei is similar to photoproduction on a free nucleon. This process is dominated by the D33 partial wave with the ηΔ(1232) intermediate state

A disease-associated gene desert directs macrophage inflammation through ETS2

Increasing rates of autoimmune and inflammatory disease present a burgeoning threat to human health1. This is compounded by the limited efficacy of available treatments1 and high failure rates during drug development2, highlighting an urgent need to better understand disease mechanisms. Here we show how functional genomics could address this challenge. By investigating an intergenic haplotype on chr21q22—which has been independently linked to inflammatory bowel disease, ankylosing spondylitis, primary sclerosing cholangitis and Takayasu’s arteritis3–6—we identify that the causal gene, ETS2, is a central regulator of human inflammatory macrophages and delineate the shared disease mechanism that amplifies ETS2 expression. Genes regulated by ETS2 were prominently expressed in diseased tissues and more enriched for inflammatory bowel disease GWAS hits than most previously described pathways. Overexpressing ETS2 in resting macrophages reproduced the inflammatory state observed in chr21q22-associated diseases, with upregulation of multiple drug targets, including TNF and IL-23. Using a database of cellular signatures7, we identified drugs that might modulate this pathway and validated the potent anti-inflammatory activity of one class of small molecules in vitro and ex vivo. Together, this illustrates the power of functional genomics, applied directly in primary human cells, to identify immune-mediated disease mechanisms and potential therapeutic opportunities